Analysts' Actions: JDSU CSCO BIG ARO AAP
Ubiquiti Networks (UBNT) downgraded at Pacific Crest to Sector Perform, Pacific Crest said. Sales are declining.
Ubiquiti Networks downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $12 price target. Company guided lower, because of counterfeiting issues.
Ubiquiti Networks downgraded at Wedbush. Shares of UBNT downgraded to Neutral from Outperform, Wedbush said. $8 price target. Counterfeiting issue to take longer to resolve.
Verisign (VRSN) downgraded at Baird from Outperform to Neutral, Robert Baird said. Valuation call, based on a $47 price target.
STOCK COMMENTS / EPS CHANGES
Alliant Techsystems (ATK) numbers boosted at Credit Suisse. Shares of ATK now seen reaching $56, according to Credit Suisse. Estimates also upped, as the company is realizing higher margins. Neutral rating. Enersys (ENS) numbers raised at Jefferies. Shares of ENS now seen reaching $43, Jefferies said. Estimates also raised on strong execution. Buy rating. ExactTarget (ET) estimates, target raised at Lazard. Shares of ET now seen reaching $32, according to Lazard. Estimates also increased, given the company's new guidance. JPMorgan (JPM) estimates cut at UBS through 2013, UBS said. Company has delayed its share buybacks. Buy rating and $46 price target. Nordstrom (JWN) estimates, target raised at Credit Suisse. Shares of JWN now seen reaching $56, according to Credit Suisse. Estimates also increased, as the company is taking market share. Neutral rating. Kohl's (KSS) numbers lowered at BMO Capital. Shares KSS now seen reaching $58, BMO Capital said. Estimates also lowered on gross margin threshold reset. Outperform rating. Medivation (MDVN) estimates, target cut at Credit Suisse. Shares of MDVN now seen reaching $120, according to Credit Suisse. Estimates also reduced, given rising operating costs. Outperform rating. Noble Energy (NBL) numbers increased at Guggenheim. NBL estimates were raised through 2013, Guggenheim said. New Falkland deal should add to earnings. Buy rating and new $120 price target. NVIDIA (NVDA) numbers raised at BMO Capital. Shares of NVDA now seen reaching $16, BMO Capital said. Estimates also raised on strong results and guide. Market Perform rating. ViroPharma (VPHM) numbers raised at Jefferies. Shares of VPHM now seen reaching $29, Jefferies said. Estimates also raised on solid 2Q12. Buy rating. >To submit a news tip, email: tips@thestreet.com.Follow TheStreet on Twitter and become a fan on Facebook.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
